Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2075 of 3284 entries
View as:

Centralized Pan-Asian Survey on the Under Treatment of Hypercholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT00687492 Org: User:
Start: 05/31/08 End: 12/31/08 Due: 12/31/09

A Phase I Study of ZD1839 and Palliative Thoracic Radiotherapy in Patients With Non-small-cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00255489 Org: User:
Start: 05/31/04 End: 06/30/06 Due: 06/30/07

Assess Safety & Efficacy of Selumetinib When Given in Combination With Standard First Line Treatment for Advanced Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01809210 Org: User:
Start: 04/04/13 End: 01/04/16 Due: 01/04/17

Phase I Study to Assess the Effect of Food on the PK and Gastrointestinal Tolerability of Selumetinib in Adolescent Children With Neurofibromatosis Type 1 Related Plexiform Neurofibromas

Phase: N/A Priority: Normal
NCT ID: NCT05101148 Org: User:
Start: 07/21/21 End: 01/12/26 Due: 01/12/27

Tezepelumab Efficacy and Safety in Reducing Oral Corticosteroid Use in Adults With Oral Corticosteroid Dependent Asthma

Phase: N/A Priority: Normal
NCT ID: NCT05398263 Org: User:
Start: 08/09/22 End: 03/24/25 Due: 03/24/26

Study to Assess the Pharmacokinetics and Safety of AZD9977 in Participants With Renal Impairment

Phase: N/A Priority: Normal
NCT ID: NCT04469907 Org: User:
Start: 06/22/20 End: 10/28/21 Due: 10/28/22

Phase I/II AZD8931/Paclitaxel in Treatment of Advanced Solid Tumours (Phase I) and Advanced Breast Cancer (Phase II)

Phase: N/A Priority: Normal
NCT ID: NCT00900627 Org: User:
Start: 06/30/09 End: 02/28/15 Due: 02/28/16

Efficacy and Safety of MEDI3506 in Adult Subjects With Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT04212169 Org: User:
Start: 12/09/19 End: 09/20/22 Due: 09/20/23

Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01711840 Org: User:
Start: 11/30/12 End: 08/31/15 Due: 08/31/16

PROACT - Pre-Operative Arimidex Compared To Tamoxifen

Phase: N/A Priority: Normal
NCT ID: NCT00232661 Org: User:
Start: 08/31/00 End: 12/31/07 Due: 12/31/08

Study to Investigate the Safety Profile of AZD4721 After Single Doses at Different Dose Levels

Phase: N/A Priority: Normal
NCT ID: NCT01889160 Org: User:
Start: 07/31/13 End: 12/31/13 Due: 12/31/14

AZD4573 in Novel Combinations With Anti-cancer Agents in Patients With Advanced Blood Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04630756 Org: User:
Start: 02/17/21 End: 02/27/25 Due: 02/27/26

Durvalumab With Stereotactic Body Radiation Therapy (SBRT) vs Placebo With SBRT in Early Stage Unresected Non-small Cell Lung Cancer (NSCLC) Patients/ Osimertinib Following SBRT in Patients With Early Stage Unresected NSCLC Harboring an EGFR Mutation

Phase: N/A Priority: Normal
NCT ID: NCT03833154 Org: User:
Start: 03/06/19 End: 04/04/28 Due: 04/04/29

Positron Emission Tomography Study Using 2-[18F]-F-A85380 to Determine α4β2 Neuronal Nicotinic Receptor Occupancy of AZD3480 After Oral Administration to Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00686413 Org: User:
Start: 01/31/08 End: 08/31/08 Due: 08/31/09

A Pharmacodynamic Study With Ticagrelor in Hispanic Patients

Phase: N/A Priority: Normal
NCT ID: NCT01523366 Org: User:
Start: 04/30/12 End: 05/31/13 Due: 05/31/14

Study to Assess the Effect of Itraconazole (a CYP3A4 Inhibitor) on the Pharmacokinetics of AZD9291, in Patients With EGFR Positive Non-small Cell Lung Cancer. Patients Will be Chosen From Those Who Have Already Been Prescribed an EGFR TKI Medicine (Such as Iressa or Tarceva)

Phase: N/A Priority: Normal
NCT ID: NCT02157883 Org: User:
Start: 11/06/14 End: 05/17/23 Due: 05/17/24

Effect of Aclidinium/Formoterol on Lung Hyperinflation, Exercise Capacity and Physical Activity in Moderate to Severe COPD Patients

Phase: N/A Priority: Normal
NCT ID: NCT02424344 Org: User:
Start: 04/27/15 End: 07/25/16 Due: 07/25/17

Rosuvastatin ORBITAL Germany

Phase: N/A Priority: Normal
NCT ID: NCT00379249 Org: User:
Start: 02/28/02 End: 02/29/04 Due: 02/28/05

Endoscopic Evidence of Maintenance of Healing With Oral NEXIUM in Patients 1 to 11 Years Old With Erosive Esophagitis.

Phase: N/A Priority: Normal
NCT ID: NCT05267613 Org: User:
Start: 07/01/22 End: 11/06/26 Due: 11/06/27

Epidemiological Study to Describe Non Small Cell Lung Cancer Clinical Management Patterns in MENA. Lung-EPICLIN/ Gulf

Phase: N/A Priority: Normal
NCT ID: NCT01562665 Org: User:
Start: 06/30/12 End: 02/28/15 Due: 02/28/16

Effect of Crestor (Rosuvastatin) on Lipid Levels in Patients With Metabolic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00815659 Org: User:
Start: 12/31/08 End: 03/31/10 Due: 03/31/11

Prevalence of Subclinical Atherosclerosis and Its Associated Factors in Hyperlipidemic Korean Adults With Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01264263 Org: User:
Start: 01/31/11 End: 04/30/11 Due: 04/30/12

European Survey of Non-Variceal Upper Gastro Intestinal Bleeding (NVUGIB)

Phase: N/A Priority: Normal
NCT ID: NCT00797641 Org: User:
Start: 01/31/09 End: 03/31/09 Due: 03/31/10

Study to Investigate Daily Symptom Variability, Symptom Effects on Morning Activities of Chronic Obstructive Disease

Phase: N/A Priority: Normal
NCT ID: NCT01110564 Org: User:
Start: 04/30/10 End: 12/31/10 Due: 12/31/11

Retrospective Study in a NSCLC M+ p

Phase: N/A Priority: Normal
NCT ID: NCT01795352 Org: User:
Start: 03/31/13 End: 10/31/13 Due: 10/31/14